STERLING, Va., Feb. 23 /PRNewswire/ -- NanoMarkets LC, a leading industry
consultancy based here, today announced the release of two White Papers that
forecast and analyze the role of nanotechnology in drug discovery and drug
delivery. The papers are available for immediate download from the firm's web
About the Papers:
In the first paper, "Nano-Enabled Drug Discovery: Seven Technologies to
Watch," NanoMarkets examines the impact that a range of new nanotechnologies
will have on the drug discovery process. Technologies discussed in this paper
include Atomic Force Microscopy, Near-field Scanning Optical Microscopes,
Surface Plasmon Resonance, Nano Mass Spectrometry, Dip-pen Nanolithography,
Nano-Arrays and Quantum Dots.
The new White Paper shows how these technologies will lead to important
improvements in drug discovery. Among the improvements that NanoMarkets
expects to see are:
* Better imaging (including real-time imaging), providing researchers
with a deeper understanding of how biological processes are affected by
a new compound.
* More sensitive fundamental research techniques for drug discovery
applications using of dip pen technology.
* Major improvements in today's microarray and fluorescent dye
NanoMarkets believes that all of these improvements will be highly valued
in a drug industry that is finding it harder to produce new drugs -- and
especially new blockbuster drugs. It is increasingly seeking new drug
discovery technologies that can improve R&D success rates and time to market.
NanoMarkets therefore believes that these improvements are likely to lead to
substantial new business revenues over the next few years.
In "Six Opportunities in Nano-Enabled Drug Delivery Systems," NanoMarkets
examines six types of drug delivery systems in which nanotechnology is likely
to have an impact: Injectable delivery systems, Implantable delivery systems,
Oral delivery systems Topical Delivery Systems, Transdermal Systems, and Toxin
Removal. As this list suggests, nanotechnological improvements promise to
impact almost every common mode of drug delivery, and nano-enabled drug
delivery is likely to be broadly felt:
* Improvements from these systems will include lower drug toxicity,
lowering cost of treatments, improved bioavailability and extension of
the economic life of proprietary drugs
* Nano-enabled drug delivery will provide improvements in the treatment
of some of the most widespread diseases, such as cancer and diabetes.
NanoMarkets believes that not only will the nano-enabled drug delivery
market be one of the first true nanomedicine markets to evolve, but that
significant revenue opportunities for participants will be created.
About NanoMarkets' Research Program:
NanoMarkets is currently conducting an extensive examination of the
opportunities for the application of nanotechnology in the pharmaceutical
sector. The first deliverables will be available in March of 2005 and will
address the major drivers, restraints and challenges for current and emerging
applications of nanotechnology in drug discovery and drug-delivery markets.
NanoMarkets is making the reports available at a discounted rate through March
11. For additional information about these reports, you may contact the firm
at firstname.lastname@example.org or (703) 430-1291 or visit http://www.nanomarkets.net
to learn more.
NanoMarkets analyzes the impact of nanotechnology on both established and
emerging markets with a focus on the realms of communications, IT,
semiconductors, bio-medical and energy. The firm provides market research
reports, customized industry analyses and general market commentary for
companies looking to capitalize on nanotechnology-based opportunities.
SOURCE NanoMarkets LC